M

McKesson

Supplies medicines and technology to healthcare teams

Principal Product Manager - HR Product Management & Employee Experience

Full-TimeUpdated on 10/23/2026
$149.6k - $199.5k+ Annual bonus + Long-term incentives
Expert
Toronto, ON, Canada
Hybrid
ProductProduct Management

About the job

Requirements
  • 12+ years of progressive experience in product management, digital strategy, transformation, human resources technology, employee experience, or related disciplines.
  • Demonstrated experience shaping enterprise-scale product portfolios, multi-year roadmaps, or complex digital transformation initiatives.
  • Experience influencing senior leaders and enterprise prioritization or investment decisions without formal authority.
  • Experience operating in large, matrixed organizations with significant cross-functional dependencies.
  • Strategic product leadership that connects workforce strategy, employee experience, technology, data, and business outcomes into a clear product direction.
  • Portfolio management across competing priorities, dependencies, sequencing, risk, and investment trade-offs across multiple product domains.
  • Executive influence to frame decision-ready recommendations and align senior stakeholders without formal authority.
  • Systems thinking to understand interactions among journeys, platforms, processes, data, and operating models across the enterprise.
  • AI and digital fluency to identify, prioritize, govern, and scale AI-enabled capabilities that improve employee experience, productivity, and business outcomes.
  • Outcome orientation, including defining success measures and managing products toward adoption, value, and continuous improvement.
Responsibilities
  • Define and evolve product strategy across multiple human resources product domains, employee journeys, and workforce capabilities.
  • Translate enterprise workforce priorities, employee insights, technology trends, and business needs into multi-year product roadmaps and investment recommendations.
  • Identify opportunities to simplify experiences, reduce fragmentation, improve adoption, and create more connected end-to-end human resources experiences.
  • Shape portfolio decisions based on measurable value, risk, adoption, compliance, feasibility, and business impact.
  • Establish portfolio-level prioritization approaches to help leaders make clear trade-offs across products, journeys, and capabilities.
  • Frame decision-ready recommendations for senior leaders, including outcomes, dependencies, risks, investment needs, and sequencing options.
  • Manage strategic dependencies across human resources product, human resources technology, employee experience, human resources services, centers of excellence, and enterprise governance forums.
  • Surface enterprise-level risks and decisions early, escalating when broader leadership alignment or investment decisions are required.
  • Lead identification, evaluation, and scaling of artificial intelligence-enabled human resources capabilities across assigned product portfolios.
  • Define product expectations for responsible artificial intelligence use, including trust, transparency, human-in-the-loop controls, quality monitoring, and escalation paths.
  • Partner with Legal, Privacy, Risk, Technology, and Compliance teams to ensure artificial intelligence-enabled capabilities meet enterprise standards and jurisdictional requirements.
  • Evaluate vendor releases, emerging technologies, and external product trends to inform future human resources product strategy.
  • Establish portfolio-level success measures tied to adoption, employee experience, operational effectiveness, self-service, cycle time, containment, and business value.
  • Maintain visibility into product performance, benefits realization, portfolio costs, and return on investment.
  • Use analytics, listening signals, service trends, workforce insights, and product adoption data to inform roadmap decisions and continuous improvement.
  • Ensure product teams move beyond feature delivery to measurable outcomes and sustained value realization.
  • Serve as a thought leader for human resources product management practices, reinforcing consistent standards, artifacts, and operating routines.
  • Create reusable frameworks for product one-pagers, decision logs, roadmap visibility, scope boundaries, success metrics, and release-readiness expectations.
  • Mentor Product Managers and matrixed partners to strengthen product thinking, prioritization discipline, and outcome orientation across human resources.
  • Advance the maturity of McKesson’s human resources product operating model by reinforcing single intake, backlog discipline, clear decision rights, and transparent trade-offs.
Desired Qualifications
  • Exposure to human resources, workforce technology, employee experience, service delivery, or regulated environments.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 23rd, 2026
Fastenal and McKesson are cash-rich stocks to buy this week; Carlisle is one to avoid

StockStory has named two cash-producing stocks to buy this week and one to avoid, saying cash generation alone doesn't make a company a winner. The stock to avoid is Carlisle (NYSE:CSL), a construction materials and weatherproofing maker with a 17% trailing 12-month free cash flow margin. StockStory cites weak organic revenue growth, projected sales growth of 5.8%, and annual earnings per share growth of just 3.6% over two years. Shares trade at $352.84, or 15.1x forward earnings. Fastenal (NASDAQ:FAST), with a 13% free cash flow margin, has a 45.3% gross margin, a 20.5% operating margin, and a 32.3% return on capital. Its shares trade at $52.32, or 38x forward earnings. McKesson (NYSE:MCK) has a 1.5% margin. Sales grew 14.5% annually over two years, and revenue reached $411 billion. Shares trade at $1,010, or 21.8x forward earnings.

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

McKesson Corporation
Oct 1st, 2026
McKesson wins Vizient's 2026 Distribution Excellence Award.

McKesson wins Vizient's 2026 Distribution Excellence Award. Vizient's 2026 Distribution Excellence Award honors suppliers that consistently deliver exceptional service and value to Vizient member health systems. September 29, 2026 In September 2026, Vizient presented McKesson with the 2026 Distribution Excellence Award at the Vizient Connections Summit in Las Vegas. The award recognizes suppliers that demonstrate superior service, support, reliability, ethics, and integrity in collaboration with Vizient.[1] Vizient, a member-owned healthcare performance improvement company, works with thousands of not-for-profit health systems and affiliates. Through its network, Vizient connects healthcare leaders with data, insights, and supplier relationships designed to drive value across the enterprise. For McKesson, the recognition reflects years of building a strategic, enterprise-wide relationship with Vizient and its member organizations at a time when health systems increasingly rely on collaborative partnerships to navigate complexity across pharmacy, supply chain, and clinical operations. Ali Cobb, Vice President of Health Systems National Accounts for McKesson Health Systems, has been central to strengthening collaboration and identifying new ways to support member needs. As workforce pressures, financial constraints, and supply chain challenges continue to shape healthcare, strong strategic partnerships remain critical to helping health systems build resilience and advance patient health. This award reflects a shared commitment by Vizient and McKesson to help health systems meet today's demands while preparing for what's next, together.

JH Consulting Online
Sep 22nd, 2026
Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer.

Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer. September 22, 2026- McKesson Medical-Surgical has announced that Cara McDonough has joined the organization as Chief Product Strategy & Supplier Partnerships Officer, effective September 14, 2026. In this role, Cara will lead McKesson Medical-Surgical's Product Strategy and Supplier Partnerships teams, guiding supplier relationship strategy and portfolio development across the company's Private Label, Pharmaceutical, Consumer Markets, and Laboratory businesses as a member of the Executive Committee. Cara brings 20 years of experience leading and growing product-focused organizations. Throughout her career, she has held senior leadership positions with nationally recognized companies, driving merchandising, private label, product strategy, and commercial growth across multiple channels, including B2B, e-commerce, and retail. Her experience building differentiated product portfolios, strengthening supplier relationships, and delivering profitable growth aligns closely with the organization's long-term strategy. As McKesson Medical-Surgical continues evolving its business, Cara's leadership will help further strengthen supplier partnerships and support the organization's commitment to delivering innovative solutions and value to customers.